What Is Preeclampsia?

Check out this answer from Consensus:

Preeclampsia is a multifaceted disorder with significant implications for maternal and fetal health. Understanding its pathophysiology, identifying risk factors, and recognizing its long-term health impacts are crucial for improving prevention, diagnosis, and treatment. Ongoing research and advancements in predictive models and therapeutic strategies hold promise for better management of this prevalent condition.

Preeclampsia is a complex hypertensive disorder that occurs during pregnancy, typically after the 20th week of gestation. It is characterized by new-onset hypertension and proteinuria, and it can lead to severe complications for both the mother and the fetus. This article explores the pathophysiology, risk factors, long-term health implications, and current research on preeclampsia.

Pathophysiology

Preeclampsia is primarily a disease of the maternal endothelium, involving systemic vascular dysfunction. The condition is marked by the release of antiangiogenic factors such as soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng), which disrupt the normal angiogenic balance and lead to endothelial dysfunction, vasoconstriction, and immune dysregulation2 8 9. These changes result in hypertension, proteinuria, and can affect multiple organ systems, including the kidneys, liver, and brain6 8.

Risk Factors

Several risk factors have been identified for preeclampsia, including chronic hypertension, gestational hypertension, diabetes (both type 1 and type 2), and gestational diabetes mellitus (GDM)4 10. Advanced maternal age, obesity, and a history of preeclampsia in previous pregnancies also increase the risk10. The condition is more prevalent in women with preexisting vascular diseases and those who receive inadequate prenatal care10.

Long-term Health Implications

Preeclampsia has significant long-term health implications for both the mother and the offspring. Women who have had preeclampsia are at an increased risk of developing cardiovascular diseases, including heart failure, coronary heart disease, and stroke1 2. The risk of chronic and end-stage kidney disease is also elevated3. Additionally, offspring of mothers with preeclampsia are more likely to develop hypertension later in life7.

Current Research and Future Directions

Recent research has focused on understanding the pathogenesis of preeclampsia and developing predictive models to identify women at higher risk. Studies have highlighted the role of abnormal placentation and the release of antiangiogenic factors in the development of the condition2 8 9. Despite the development of multiple prediction models, their clinical implementation remains limited due to variability in predictive accuracy and the need for further validation5. Efforts are also being made to develop therapeutic strategies targeting the angiogenic pathway and to improve disease-risk stratification using angiogenic biomarker assays2. Low-dose aspirin is currently recommended for prophylaxis in high-risk populations, but more research is needed to identify additional therapeutic targets and improve treatment outcomes8 10.